Outlook: British Biotech
Tuesday 16 February 1999
First there was the grand dream of creating a "New Glaxo", a whizzy pharmaceutical giant based on some unproven compounds. Then came the bitter tussle with Andrew Millar, its former chief scientist, who was sacked for examining clinical data on the company's leading products and blowing the whistle on overoptimistic statements. The corker of a row triggered two investigations by stock exchange authorities, a Parliamentary enquiry and a collapse in the share price. The faces around the boardroom table changed since then but the results have remained the same, witness yesterday's trial failure, which at least partially vindicates Dr Millar's actions.
The new men in charge claim that Marimastat can still work on other cancers and that there are nine other studies to prove it. Shareholders should be patient, they say, these are early days, give us another year. But this is asking a lot of investors who have seen the value of their shares plunge by almost 93 per cent over the past five years. After yesterday's events, there must be a serious question over the future of British Biotech.
The company has a strong balance sheet with cash of over pounds 100m. And it is only a couple of years since this company was the rising star in Britain's rapidly growing biotech sector. But given the dreadful track record and uncertain prospects perhaps the board should finally admit defeat.Would it not now be the honourable course to return the cash to the long-suffering investors and draw the curtains on this sorry tale?
- 1 A daily walk 'can add seven years to your life'
- 2 Rules on 5p plastic bags likely to lead to arguments at the check-out
- 3 Chrissie Hynde says women who 'wear high heels and dress provocatively entice rapists'
- 4 Blood Moon and Supermoon: September to bring brightest – and dimmest – full Moon of the year on same night
- 5 News agency criticised for describing Amal Clooney as 'actor's wife' in coverage of human rights trial
University to mark down students who say 'illegal immigrants' in class
Rules on 5p plastic bags likely to lead to arguments at the check-out
The nine most warmongering countries in the world revealed
Blood Moon and Supermoon: September to bring brightest – and dimmest – full Moon of the year on same night
VMAs 2015: Taylor Swift wins big, Kanye West runs for president, Nicki Minaj calls out Miley Cyrus and all of tonight's winners
Climate change: 2015 will be the hottest year on record 'by a mile', experts say
'Women only' train carriages: Jeremy Corbyn unveils radical move to tackle public harassment
Black holes are a passage to another universe, says Stephen Hawking
Tony Blair attacks Jeremy Corbyn's 'Alice In Wonderland' politics
Theresa May says migrants should be banned from entering the UK unless they have jobs lined up
Iain Duncan Smith 'should resign over disability benefit death figures', says Jeremy Corbyn
iJobs Money & Business
£25000 - £30000 per annum: Recruitment Genius: From modest beginnings the comp...
£35000 - £40000 per annum: Recruitment Genius: From modest beginnings the comp...
£15000 - £65000 per annum: Recruitment Genius: This is an exciting opportunity...
£18000 - £20000 per annum: Recruitment Genius: This is a fantastic opportunity...